| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.007 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |